Zin Che Anis Jauharah Che Mohd, Ishak Wan Rosli Wan, Khan Nurzalina Abdul Karim, Mohamed Wan Mohd Izani Wan
Nutrition Program, School of Health Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia.
Discipline of Pharmaceutical Technology, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Minden, Penang, Malaysia.
Int J Health Sci (Qassim). 2024 Sep-Oct;18(5):16-27.
There is emerging evidence of the benefits of in improving metabolic profiles in people with diabetes. This study was conducted to analyze the effect of aqueous extract on the metabolic control of patients with type 2 diabetes in Malaysia.
A powdered drink formulated with 2.5 g of extract was prepared as a test food. An intervention study was conducted with 50 participants randomly assigned to an intervention or a control group. Anthropometric, biochemical, and clinical variables were assessed at baseline and week 12 after intervention. Paired T-tests were applied to compare the mean differences between the baseline and post-intervention for each variable.
The intervention group presented a significant reduction in diastolic blood pressure (Δ -7.0 mmHg, 95% confidence interval [CI]: -11.4, -2.5). Mean fasting plasma glucose (Δ -0.8 mmol/L, 95% CI: -1.8, 0.2) showed a greater reduction in the intervention group compared to the control group (Δ -0.4 mmol/L, 95% CI: -1.2, 0.4). Mean lean body mass showed a favorable trend of increment at week 6 (Δ 0.05 kg, 95% CI: -0.40, 0.49) and week 12 (Δ 0.16 kg, 95% CI: -0.33, 0.64) as compared to baseline in the intervention group but not in the control group which manifested decreasing lean body mass.
The use of extract may potentially improve blood pressure and glycemic control in patients with type 2 diabetes and it may be an attractive candidate for the development of functional food products.
越来越多的证据表明,[提取物名称]对改善糖尿病患者的代谢状况有益。本研究旨在分析[提取物名称]水提取物对马来西亚2型糖尿病患者代谢控制的影响。
将含有2.5克[提取物名称]提取物的粉末饮料制备成测试食品。对50名参与者进行了一项干预研究,他们被随机分配到干预组或对照组。在基线和干预后第12周评估人体测量学、生化和临床变量。应用配对t检验比较每个变量在基线和干预后之间的平均差异。
干预组舒张压显著降低(Δ -7.0 mmHg,95%置信区间[CI]:-11.4,-2.5)。与对照组(Δ -0.4 mmol/L,95% CI:-1.2,0.4)相比,干预组的平均空腹血糖(Δ -0.8 mmol/L,95% CI:-1.8,0.2)降低幅度更大。与干预组的基线相比,干预组在第6周(Δ 0.05 kg,95% CI:-0.40,0.49)和第12周(Δ 0.16 kg,95% CI:-0.33,0.64)时平均瘦体重呈现出有利的增加趋势,而对照组的瘦体重则呈下降趋势。
使用[提取物名称]提取物可能有助于改善2型糖尿病患者的血压和血糖控制,它可能是功能性食品开发的一个有吸引力的候选物。